Unsupported off-label chemotherapy in metastatic colon cancer

Unsupported off-label chemotherapy in metastatic colon cancer

<p>Abstract</p> <p>Background</p> <p>Newer systemic therapies have the potential to decrease morbidity and mortality from metastatic colorectal cancer, yet such therapies are costly and have side effects. Little is known about their non-evidence-based use.</p> <...

Full description

Bibliographic Details
Main Authors: de Souza Jonas A, Polite Blase, Perkins Monica, Meropol Neal J, Ratain Mark J, Newcomer Lee N, Alexander G Caleb
Format: Article
Language:English
Published: BMC 2012-12-01
Series:BMC Health Services Research
Subjects:
Colorectal cancer
Off-label
Evidence-based medicine
Physician practice patterns
Online Access:http://www.biomedcentral.com/1472-6963/12/481

Similar Items

Similar Items